Welcome to LookChem.com Sign In|Join Free
  • or
methyl 2-[1-(1,4,7,10-tetraazacyclododecane)]-2-(4-(2-(trimethylsilyl)ethynyl)-phenyl)acetate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

950744-29-3

Post Buying Request

950744-29-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

950744-29-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 950744-29-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,0,7,4 and 4 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 950744-29:
(8*9)+(7*5)+(6*0)+(5*7)+(4*4)+(3*4)+(2*2)+(1*9)=183
183 % 10 = 3
So 950744-29-3 is a valid CAS Registry Number.

950744-29-3Relevant academic research and scientific papers

Synthesis of novel 1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid (DOTA) derivatives for chemoselective attachment to unprotected polyfunctionalized compounds

Knoer, Sebastian,Modlinger, Armin,Poethko, Thorsten,Schottelius, Margret,Wester, Hans-Juergen,Kessler, Horst

, p. 6082 - 6089 (2008/02/13)

A convenient synthesis of novel bifunctional poly(amino carboxylate) chelating agents allowing chemoselective attachment to highly functionalized biomolecules is described. Based on the well known chelator 1,4,7,10- tetraazacyclodecane-l,4,7,10-tetraacetic acid (DOTA), we synthesized novel bifunctional chelating agents bearing additional functional groups by alkylating 1,4,7,10-tetraazacyclododecane (cyclen) with one equivalent of para-functionalized alkyl 2-bromophenyl-acetate and three equivalents of tert-butyl 2-bromoacetate. The resulting compounds, which contain an additional carbonyl or alkyne functionality, allow site specific labeling of appropriately functionalized unprotected biomolecules in a rapid manner via click reactions. This was demonstrated by the attachment of our new DOTA derivatives to the somatostatin analogue Tyr3-octreotate by chemoselective oxime ligation and CuI-catalyzed azide-alkyne cycloaddition. Initial biodistribution studies in mice with the radiometalated compound demonstrated the applicability of the described DOTA conjugation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 950744-29-3